Research

Where You Are:

Moffitt Cancer Center is one of 41 NCI-designated comprehensive cancer centers in the country and the only one based in Florida. The designation is bestowed upon institutions that have significant peer-reviewed research funding; high-quality programs in basic, translational and population research; are dedicated to developing more effective approaches to cancer prevention, diagnosis and therapy; educate health care professionals and the public; and reach out to underserved populations.

Moffitt's impact on cancer research spans basic science, prevention and clinical research with a focus on translating discoveries into better care.

Research Disciplines | Clinical Trials | Research Cores & Technology | Find a Researcher  | Conflict of Interest


Moffitt Research News

Differences in Tumor Cell Metabolism Affect Tumor Growth, Invasion, Response to Therapy, says Moffitt Cancer Center Researchers

TAMPA, Fla. (May 18, 2015) – Cells within a tumor are not the same; they may have different genetic mutations and different characteristics during growth and throughout treatment. These differences make treating tumors extremely difficult and often lead to tumor recurrence dominated by more aggressive tumor cells. Moffitt Cancer Center researchers are using mathematical modeling to characterize these differences within a tumor and hope that the results of their latest study will lead to better therapeutic treatments. Learn more...

Androgen Deprivation Therapy May Lead to Cognitive Impairment in Prostate Cancer Patients, Say Moffitt Cancer Center Researchers

TAMPA, Fla(May 12, 2015) – Cognitive impairment can occur in cancer patients who are treated with a variety of therapies, including radiation therapy, hormone therapy, and chemotherapy.  After chemotherapy treatment it is commonly called “chemo brain.” Signs of cognitive impairment include forgetfulness, inability to concentrate, problems recalling information, trouble multi-tasking and becoming slower at processing information. The number of people who experience cognitive problems following cancer therapy is broad, with an estimate range of 15 to 70 percent. Learn more...

 

Moffitt Cancer Center Researchers Work to Determine Why Some Prostate Cancer Patients Experience More Hot Flashes during Therapy

TAMPA, Fla(May 7, 2015) – Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Moffitt Cancer Center researchers are working to determine what genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy.   Learn more...


 
x
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions